CLEVELAND — Remdesivir is the only FDA approved treatment for COVID-19, but it's limited regarding who can receive it. The agency gave emergency use authorization to some other monoclonal antibody and anti-viral treatments, but the omicron variant may be a game changer with what works.
Now, there's an experimental cancer drug that may help save the lives of COVID patients. This episode of "Health Yeah! with Monica Robins" features infectious disease expert Robert Salata, MD from University Hospitals Cleveland Medical Center.
Salata is the STERIS Chair of Excellence in Medicine and has been chairman of the department of medicine since 2015, and was chief of the division of infectious diseases and HIV medicine for nearly 20 years at Case Western Reserve University and UH Cleveland Medical Center. He is also the founding director of the Infectious Diseases and Immunology Institute in the School of Medicine, and also medical director of infection control and prevention at UH Cleveland Medical Center.
In this podcast, Monica and Salata discuss drugs to tackle COVID-19, the future of our vaccines, and what still keeps Salata up at night despite the rest of us thinking the pandemic is behind us (spoiler: It's not). First up, his thoughts on an experimental cancer drug called sabizabulin that may help reduce the risk of death in COVID patients.
Previous episodes of 'Health Yeah!':